<DOC>
	<DOCNO>NCT00221156</DOCNO>
	<brief_summary>The purpose study determine whether intervention newly diagnose abnormal glucose tolerance coronary stenting improve long-term clinical outcome .</brief_summary>
	<brief_title>Acarbose Secondary Prevention After Coronary Stenting</brief_title>
	<detailed_description>Recent study demonstrate newly diagnose abnormal glucose tolerance ( AGT ; diabetes mellitus impair glucose tolerance ) common among patient ischemic heart disease . Several large cohort study indicate people prediabetic condition , impair glucose tolerance , raise risk future cardiovascular disease . Intervention acarbose prevent myocardial infarction cardiovascular disease type 2 diabetic IGT patient . However , effect acarbose secondary prevention myocardial infarction cardiovascular event patient newly diagnose AGT coronary stenting remain unclear . The purpose present study determine whether intervention abnormality coronary stenting improve long-term clinical outcome . This open , randomize study compare acarbose versus standard lifestyle modification . Patients 1:1 chance receive acarbose versus standard lifestyle modification . There research evidence suggest acarbose may improve clinical outcome patient type 2 diabetes IGT patient .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Glucose Metabolism Disorders</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Within 8 week since implantation coronary artery stent stable angina pectoris acute coronary syndrome . Abnormal glucose tolerance accord 75 g oral glucose tolerance test ( OGTT ) . HbA1c le 6.5 % . Age 20 75 year ( time consent ) . Patients give informed consent writing . Patients abnormal glucose tolerance cause organic disorder pancreatitis , hemochromatosis , post pancreatectomy , hyperthyroidism , Cushing syndrome , PraderWilli syndrome , etc . Patients plan angioplasty . Patients uncontrollable congestive heart failure . Less 6 month since last episode cerebral infarction . Patients receive medication diabetes mellitus . AST ( GOT ) exceed 100 IU/L ALT ( GPT ) exceed 100 IU/L . Creatinine exceed 2 mg/dl . Patients history ileus less 6 month since celiotomy . Pregnant woman plan become pregnant , lactation period . Habitual drinker ( 100 ml/day alcohol ) . Patients history gastrectomy . Patients impossible follow 5 year . Any reason clinical supervisor clinical researcher may consider case unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Abnormal Glucose Tolerance</keyword>
	<keyword>coronary artery disease</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>clinical outcome</keyword>
</DOC>